Diabetes Mellitus, Type 2 D003924

Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Glucose Metabolism Disorders » Diabetes Mellitus » Diabetes Mellitus, Type 2

Diseases [C] » Endocrine System Diseases [C19] » Diabetes Mellitus » Diabetes Mellitus, Type 2

Description

A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.   MeSH

Subtype Terms (1)


Phase 4 Indicated Drugs (175)

Phase 3 Indicated Drugs (111)

Phase 2 Indicated Drugs (250)

Phase 1 Indicated Drugs (167)

Other Experimental Indicated Drugs (153)


Organization Involved with Phase 4 Indications (337)

Aarhus University

Abbott

Ajou University

Aristotle University of Thessaloniki

Astellas

AstraZeneca

Atlanta Research and Education Foundation

AURAL - Colmar

AURAL de Strasbourg

AURAL - Mulhouse

Barnsley Hospital

Baskent University

Bayer

Baylor University

B. Braun

Boehringer Ingelheim

Bristol-Myers Squibb

Cairo University

Capital Medical University

Cardiology, University and Emergency Hospital, Bucharest, Romania

Carl T. Hayden Medical Research Foundation

Case Western Reserve University

Catholic University of Korea

Cedars-Sinai Medical Center

Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète

Centro de Diabetes Curitiba

Chang Gung University

Changhua Christian Hospital

Charles Drew University

Charles University

CH de Mulhouse

Chemical Resources

Chiangmai University

Chinese Academy of Medical Sciences

Chinese Diabetes Society

Chinese University of Hong Kong

Chong Kun Dang Pharmaceutical

CHRISTUS Santa Rosa Hospital

CH Sud Francilien

Chung-Ang University

Clalit Health Services

Clinical Research Centre, Malaysia

Clinical Research Institute HUCH Ltd

Consano Clinical Research, LLC

Cornell University

Daiichi Sankyo

Damanhour University

Department of Veteran Affairs

Dexa Medica Group

Diabetes Foundation, India

Diabeteszentrum Bad Lauterberg

Dnipropetrovsk State Medical Academy

Dokkyo Medical University

Dong-A Pharmaceutical

Dongguk University

Duke University

East Carolina University

East Tennessee State University

Eisai

Eli Lilly

Emek Medical Center

Emory University

Esbjerg Hospital

Eulji University

Federal University of Rio Grande do Sul

Forest Laboratories

Free University of Amsterdam

Fresenius

Fudan University

Fundación Canaria Rafael Clavijo para la Investigación Biomédica

Fundación Fernández-Cruz

Fundacion Investigacion Interhospitalaria Cardiovascular

Fundación Pública Andaluza

General Hospital Dr. J. Bencevic

Georgetown University

George Washington University

Gilead Sciences

GlaxoSmithKline

Gottfried Wilhelm Leibniz Universität Hannover

Government of China

Government of Mexico

Government of Russia

Government of Singapore

Government of Spain

Guerbet

Gulf Regional Research & Educational Services, LLC

GWT-TUD GmbH

Handok Pharmaceuticals Co., Ltd.

Hanyang University

Harvard University

Haugaard, Steen Bendix, M.D., DMSc

Haydarpasa Numune State Hospital

Hebrew University

Herz- und Diabeteszentrum NRW

Hoosier Cancer Research Network

Hospices Civils de Colmar

Hospital de Base

Hospital Universitario Central de Asturias

Hospital Virgen de la Victoria

Huashan Hospital

Huazhong University

Humboldt University

IInstituto Gallego de Medicina Vascular

ikfe GmbH

India Diabetes Research Foundation

Informed Data Systems

Inje University

Instituto Nacional de Ciencias Medicas y Nutricion

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

International Diabetes Center, Minneapolis, MN 55416

Isfahan University

Japan Heart Foundation

Jiao Tong University

Jilin University

Johannes Gutenburg University

Johns Hopkins University

Johnson and Johnson

Joslin Diabetes Center

Jothydev's Diabetes and Research Centre

Juntendo University

JW Pharmaceutical

Kanazawa University

Kangbuk Samsung Hospital

Kansai Electric Power Hospital

Karolinska Institute

Khoo Teck Puat Hospital

King Edward Medical University

Kissei Pharmaceuticals

Kitasato University

Korea University

Kowa

Kuhnil Pharmaceutical Co., Ltd.

Kumamoto University

Kyung Hee University

Laboratoires Teriak

Laboratorios Silanes S.A. de C.V.

LaborMed Pharma S.A.

Laniado Medical Center

Lantheus Medical Imaging

Leiden University

Lerdsin General Hospital

LG

LMC Diabetes & Endocrinology Ltd.

LM Diagnósticos S.L.

Loyola University

Ludwig Maximilians University

Lund University

Maastricht University

Mackay Medical College

Magna Graecia University

Materia Medica Holding

Mayo Clinic

McMaster University

Medical University of Graz

Medical University of South Carolina

Medical University of Vienna

Menzies School of Health Research

Merck

Merck KGaA

Milton S. Hershey Medical Center

Mitsubishi Tanabe

Monash University

Mountain Diabetes and Endocrine Center

Nang Kuang Pharmaceutical Co., Ltd.

Nanjing Medical University

Nanjing University

Nanyang Technological University

Nara Medical University

National Cerebral and Cardiovascular Center

National Cheng Kung University

National Heart, Lung, and Blood Institute (NHLBI)

National Institute for Health Research, United Kingdom

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Nutrition and Food Technology Institute

National Taiwan University

Newcastle University

Novartis

Novo Nordisk

Oakland University

Odense University Hospital

Ohio State University

Ohio University

Oregon Health and Science University

Orient Europharma Co., Ltd.

Osaka University

Otsuka

Peking University

Pennsylvania State University

People's Liberation Army of China

Pfizer

Pierre and Marie Curie University

Postgraduate Institute of Medical Education and Research

Poznan University

Procter and Gamble

Profil GmbH

Profil Mainz GmbH & Co KG

Pusan National University Hospital

Radboud University

Research Clinical Centre of the Russian Railways, JSC

Rovira i Virgili University

Royal Surrey County Hospital

Ruhr University Bochum

Rush University

Russian Federal Research Endocrinology center

RWTH Aachen University

Samuel Lunenfeld Research Institute

Sanofi

Sapienza University of Rome

Sciema

Seoul National University

Services Hospital, Lahore

Services Institute of Medical Sciences, Pakistan

Servier

Shandong Province Qianfoshan Hospital

Shantou University

Shiga University

Southeast University

Southern Medical University

Spanish Society of Cardiology

Srinakharinwirot University

Stanford University

State University of New York, Buffalo

Steno Diabetes Center

St. Paul Heart Clinic

Sungkyunkwan University

Sun Yat-Sen University

Taichung Veterans General Hospital

Taipei Veteran General hospital

Takeda

Tameside General Hospital

Tameside Hospital NHS Foundation Trust

Technical University of Munich

Technion University

Tel Aviv University

Temple University

Texas Tech University

The Deutsche Diabetes Forschungsgesellschaft e.V.

The Royal Bournemouth Hospital

The University of Hong Kong

The University of Texas, Dallas

TIMI Study Group, Boston, MA

TSH Biopharm Corporation Limited

Tsinghua University

Tulane University

United States Army

Universidad Autonoma de Barcelona

Universidad Autonoma de Ciudad Juarez

Universidad Complutense de Madrid

Universidad de Guanajuato

Université catholique de Louvain

University Hospital, Gentofte, Copenhagen

University of Alabama, Birmingham

University of Amsterdam

University of Andalas

University of Barcelona

University of Bergen

University of Birmingham

University of British Columbia

University of Burgundy

University of California, Riverside

University of Campania Luigi Vanvitelli

University of Campinas

University of Cincinnati

University of Colorado

University of Copenhagen

University of Dhaka

University of Dundee

University of Exeter

University of Florida

University of Freiburg

University of Glasgow

University of Gothenburg

University of Grenoble

University of Guadalajara

University of Heidelberg

University of Helsinki

University of Indonesia

University of Ioannina

University of Jordan

University of L'Aquila

University of Leicester

University of Ljubljana

University of London

University of Lorraine

University of Malaya

University of Maryland

University of Miami

University of Michigan

University of Missouri

University of Naples Frederico II

University of Oslo

University of Otago

University of Padova

University of Palermo

University of Paris

University of Pavia

University of Pennsylvania

University of Picardie Jules Verne

University of Pittsburgh

University of Rochester

University of Sao Paulo

University of South Carolina

University of Southern Denmark

University of Strasbourg

University of Texas at Houston

University of Texas, Galveston

University of Texas, San Antonio

University of Toronto

University of Toulouse

University of Tuebingen

University of Turin

University of Turku

University of Ulsan

University of Utah

University of Vermont

University of Vienna

University of Vigo

University of Virginia

University of Washington

University of Western Ontario

University of Yaounde

University of Zagreb

University Putra Malaysia

Uppsala University

Valenciennes Hospital Centre

Vanderbilt University

Virginia Commonwealth University

Vita-Salute University of Milano. Italy

VU University of Amsterdam

Washington University in St. Louis

West Side Institute for Science and Education

Xiamen University

Xijing Hospital

Yale University

Yonsei University

Yuhan Pharmaceutical Company

Zhejiang University

Organization Involved with Phase 3 Indications (136)

Key: D003924 (135) Subtype (1)

Organization Involved with Phase 2 Indications (221)

Achieve Clinical Research, LLC

ActivX Biosciences, Inc.

Akcea Therapeutics

Akros

Albany Medical College

Alizyme

ALK-Abello, S.A.

Allegheny Health Network

Allegheny Singer Research Institute

Alliance Against Diabetes / AAD Clinical Research

American Institute of Research

Amrita Institute of Medical Sciences

ANS Pharma

Apex Bioscience

Ardelyx

ARKAY Therapeutics

Association for Innovation and Biomedical Research on Light and Image (AIBILI)

Association of International Professionals, dba Nevada Alliance Against Diabetes

AXIS Clinicals Limited

Bangalore Diabetes Centre

Barts & The London NHS Trust

Bastyr University

Bellus Health Inc

Bharti Research Institute of Diabetes & Endocrinology

BHV Pharma

Big Sky Clinical Research

Bio-K Plus International Inc.

Biose

Boston Therapeutics

BYL Nair Hospital

Castlerock Clinical Research Consultants, LLC

Celerion

Charlotte Clinical Research

ChemoCentryx

China Medical University

Christian Medical College, Vellore, India

Clinical Trial Consultants AB

Coastal Carolina Research

Columbia University

Compass Research

Concert Pharmaceuticals

ConjuChem Biotechnologies Inc.

CPEX Pharmaceuticals

Craig S Thompson MD LLC

Creekside Endocrine Associates

Dallas Diabetes and Endocrine Center

Dance Biopharm Inc.

Dartmouth University

Dasman Diabetes Institute

Deenanath Mangeshkar Hospital & Research Centre

DGD Research

Diabetes Thyroid Hormone Research Institute Pvt. Ltd.

Diablo Clinical Research

Diacon Hospital, Bangalore

DiaMedica USA Inc.

Dr. V. Seshiah Diabetes Care & Research Institute

Organization Involved with Other Experimental Indications (117)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.